FDA chief explains changes to "black box" warnings on some hormone therapies for menopause
FDA commissioner Dr. Marty Makary joins "CBS Mornings" to discuss the agency's announcement Thursday that boxed warnings will be removed from many estrogen products used for hormone therapy, a treatment that helps alleviate the symptoms of menopause.
FDA commissioner Dr. Marty Makary joins "CBS Mornings" to discuss the agency's announcement Thursday that boxed warnings will be removed from many estrogen products used for hormone therapy, a treatment that helps alleviate the symptoms of menopause.
Read the full article at:
CBS News →